Neuroimaging in chronic fatigue syndrome

Area of Science:

• Neurology
• Medical Imaging

Background:

• Chronic Fatigue Syndrome (CFS) diagnosis is challenging due to the lack of specific biomedical markers.
• Diagnosis relies heavily on subjective patient information aligning with clinical case definitions.
• Cognitive difficulties and headaches in CFS patients often prompt neuroimaging referrals.

Purpose of the Study:

• To evaluate the utility of neuroimaging in assessing Chronic Fatigue Syndrome (CFS).
• To review studies utilizing static Magnetic Resonance Imaging (MRI) for structural abnormalities.
• To review studies assessing regional cerebral blood flow (rCBF) using Single-Photon Emission Computed Tomography (SPECT).

Main Methods:

• Review of static Magnetic Resonance Imaging (MRI) studies for structural brain abnormalities in CFS.
• Review of Single-Photon Emission Computed Tomography (SPECT) studies measuring regional cerebral blood flow (rCBF) in CFS.
• Exploration of future neuroimaging technologies such as Positron Emission Tomography (PET).

Main Results:

• Static MRI studies assess structural abnormalities in CFS patients.
• SPECT studies evaluate regional cerebral blood flow (rCBF) changes in CFS.
• The review highlights the need to consider confounding factors in neuroimaging research.

Conclusions:

• Neuroimaging, including MRI and SPECT, plays a role in evaluating potential brain changes in CFS.
• Future research should incorporate advanced techniques like PET and address confounding factors such as psychopathology and neurological diseases.
• Standardizing neuroimaging methodologies is crucial for reliable CFS evaluation.